NewLeaf Symbiotics

NewLeaf Symbiotics was formed in 2012 to develop and commercialize one of the most prevalent, beneficial bacteria found in nature: PPFMs (Pink Pigmented Facultative Methylotrophs). NewLeaf Symbiotics is the exclusive licensee of a number of patents on the use of this family of bacteria. NewLeaf Symbiotics has also filed its own related patents, and is actively developing new technologies related to PPFMs. The Company is engaged in laboratory, greenhouse, and field product trials and expects to commercialize and license products beginning in 2014.

Company Growth (employees)

Type

Private

St. Louis, US

Founded

1999

Size (employees)

24 (est)-4%

Website

newleafsym.com

NewLeaf Symbiotics was founded in 1999 and is headquartered in St. Louis, US

Key People at NewLeaf Symbiotics

Thomas Laurita

President and CEO

Stephen Kahn

Senior VP and CFO

Gregg Bogosian

Chief Scientist

Marcus Jones

Vice President, Product Development

Jim Budzynski

VP Business Development and CTO

NewLeaf Symbiotics Office Locations

NewLeaf Symbiotics has an office in St. Louis

St. Louis, US (HQ)

1005 North Warson Road

NewLeaf Symbiotics Data and Metrics

Summary Metrics

Founding Date	1999
Total Funding	$51.6 m
Latest funding size	$24 m
Time since last funding	12 days
Investors	RockPort Capital Partners, RockPort Capital, Otter Capital, Monsanto Growth Ventures (MGV), Open Prairie, Palo Alto Investors, Pangaea Ventures, Lewis & Clark Ventures